Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 2,483,373 | 2,379,183 | 2,222,769 | 2,227,191 | 2,271,692 |
| Cost of Goods | 515,520 | 477,360 | 438,900 | 443,710 | 526,410 |
| Gross Profit | 1,887,740 | 1,900,510 | 1,748,250 | 1,792,020 | 1,745,280 |
| Operating Expenses | 1,162,490 | 1,152,810 | 1,097,620 | 1,262,160 | 1,084,530 |
| Operating Income | 805,883 | 749,373 | 687,149 | 522,031 | 661,162 |
| Other Income | -113,343 | -38,993 | -73,779 | -37,161 | 47,048 |
| Pre-tax Income | 692,540 | 710,380 | 613,370 | 484,870 | 708,210 |
| Income Tax | 163,580 | 163,320 | 141,050 | 128,690 | 170,080 |
| Net Income Continuous | 546,592 | 547,353 | 480,017 | 412,410 | 538,128 |
| Net Income | $546,592 | $547,353 | $480,017 | $412,410 | $538,128 |
| EPS Basic Total Ops | 0.09 | 0.09 | 0.08 | 0.07 | 0.09 |
| EPS Basic Continuous Ops | 0.09 | 0.09 | 0.08 | 0.07 | 0.09 |
| EPS Diluted Total Ops | 0.09 | 0.09 | 0.08 | 0.07 | 0.09 |
| EPS Diluted Continuous Ops | 0.09 | 0.09 | 0.08 | 0.07 | 0.09 |
| EBITDA(a) | $805,883 | $749,373 | $687,149 | $1,003,101 | $661,162 |